
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-a68b4900.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-0a3f24ce.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Successful treatment of an elderly patient with lung squamous cell carcinoma by tislelizumab and chemotherapy: a case report with novel imaging findings - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="5BB8CA4F81CDB50307CA4F0013457E5E.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="frontimmu">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11973309/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Frontiers in Immunology">
<meta name="citation_title" content="Successful treatment of an elderly patient with lung squamous cell carcinoma by tislelizumab and chemotherapy: a case report with novel imaging findings">
<meta name="citation_author" content="Lufan Xu">
<meta name="citation_author_institution" content="Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China">
<meta name="citation_author" content="Xinxin Ma">
<meta name="citation_author_institution" content="Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China">
<meta name="citation_author" content="Yang Yang">
<meta name="citation_author_institution" content="Nantong Tumor Hospital, Tumor Hospital Affiliated to Nantong University, Nantong, China">
<meta name="citation_author" content="Zhiqiang Ding">
<meta name="citation_author_institution" content="Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China">
<meta name="citation_author" content="Yi Luo">
<meta name="citation_author_institution" content="Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China">
<meta name="citation_publication_date" content="2025 Mar 24">
<meta name="citation_volume" content="16">
<meta name="citation_firstpage" content="1543114">
<meta name="citation_doi" content="10.3389/fimmu.2025.1543114">
<meta name="citation_pmid" content="40196110">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11973309/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11973309/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11973309/pdf/fimmu-16-1543114.pdf">
<meta name="description" content="The advent of immunotherapy has transformed the therapeutic landscape for inoperable, locally advanced Non-Small cell lung cancer (NSCLC), particularly for lung squamous cell carcinoma (LUSC) with a predominance of negative driver genes. Based on ...">
<meta name="og:title" content="Successful treatment of an elderly patient with lung squamous cell carcinoma by tislelizumab and chemotherapy: a case report with novel imaging findings">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="The advent of immunotherapy has transformed the therapeutic landscape for inoperable, locally advanced Non-Small cell lung cancer (NSCLC), particularly for lung squamous cell carcinoma (LUSC) with a predominance of negative driver genes. Based on ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11973309/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="11973309">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.3389/fimmu.2025.1543114"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/fimmu-16-1543114.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC11973309%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/11973309/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/11973309/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC11973309/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-frontimmu.gif" alt="Frontiers in Immunology logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Frontiers in Immunology" title="Link to Frontiers in Immunology" shape="default" href="http://www.frontiersin.org/immunology" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Front Immunol</button></div>. 2025 Mar 24;16:1543114. doi: <a href="https://doi.org/10.3389/fimmu.2025.1543114" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.3389/fimmu.2025.1543114</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Front%20Immunol%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Front%20Immunol%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Front%20Immunol%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Front%20Immunol%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Successful treatment of an elderly patient with lung squamous cell carcinoma by tislelizumab and chemotherapy: a case report with novel imaging findings</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xu%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Lufan Xu</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Lufan Xu</span></h3>
<div class="p">
<sup>1</sup>
Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xu%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lufan Xu</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ma%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Xinxin Ma</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Xinxin Ma</span></h3>
<div class="p">
<sup>1</sup>
Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ma%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xinxin Ma</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yang%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Yang Yang</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Yang Yang</span></h3>
<div class="p">
<sup>2</sup>
Nantong Tumor Hospital, Tumor Hospital Affiliated to Nantong University, Nantong, China
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yang%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yang Yang</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ding%20Z%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Zhiqiang Ding</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Zhiqiang Ding</span></h3>
<div class="p">
<sup>1</sup>
Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ding%20Z%22%5BAuthor%5D" class="usa-link"><span class="name western">Zhiqiang Ding</span></a>
</div>
</div>
<sup>1,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Luo%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Yi Luo</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Yi Luo</span></h3>
<div class="p">
<sup>1</sup>
Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Luo%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yi Luo</span></a>
</div>
</div>
<sup>1,</sup><sup>*</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>1</sup>
Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China
</div>
<div id="aff2">
<sup>2</sup>
Nantong Tumor Hospital, Tumor Hospital Affiliated to Nantong University, Nantong, China
</div>
<div class="author-notes p">
<div class="fn" id="fn1"><p>Edited by: Valentina De Falco, National Research Council (CNR), Italy</p></div>
<div class="fn" id="fn2">
<p>Reviewed by: Dipendra Khadka, NADIANBIO Co. Ltd. Wonkwang University School of Medicine, Republic of Korea</p>
<p>Bing Feng, Pennington Biomedical Research Center, United States</p>
</div>
<div class="fn" id="fn001">
<sup>✉</sup><p class="display-inline">*Correspondence: Zhiqiang Ding, <span>13813011835@163.com</span>; Yi Luo, <span>Robertluoyi@126.com</span>
</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2024 Dec 10; Accepted 2025 Feb 24; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Copyright © 2025 Xu, Ma, Yang, Ding and Luo</div>
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC11973309  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40196110/" class="usa-link">40196110</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>The advent of immunotherapy has transformed the therapeutic landscape for inoperable, locally advanced Non-Small cell lung cancer (NSCLC), particularly for lung squamous cell carcinoma (LUSC) with a predominance of negative driver genes. Based on the results of clinical trials such as KEYNOTE-042 and KEYNOTE-407, PD-1/PD-L1 inhibitors are now recognized as the standard of care for first-line or second-line treatment in many countries. Among the 17 immune checkpoint inhibitors sanctioned in China, tislelizumab, a domestically developed PD-1 inhibitor, enjoys broad application. Here, we present a case of a patient with LUSC who attained complete remission by cyst formation with the combination of tislelizumab and chemotherapy. Despite the absence of expression data for this patient, imaging studies revealed a reduction in the primary lesion size and the emergence of an uncommon cystic alteration post-treatment with sequential immunochemotherapy and tislelizumab monotherapy. As per the most recent follow-up, the lesion has vanished entirely. This outcome holds significant implications for the treatment of driver gene-negative LUSC by tislelizumab.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> lung squamous cell carcinoma, tislelizumab, PD-1 inhibitor, immunotherapy, chemotherapy</p></section></section><section id="s1"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>Data from 2022 (<a href="#B1" class="usa-link" aria-describedby="B1">1</a>) reveal that lung cancer continues to hold the highest incidence and mortality rates globally. Non-Small cell lung cancer (NSCLC) constitutes the majority of lung cancer cases (<a href="#B2" class="usa-link" aria-describedby="B2">2</a>), among which 20-30% are lung squamous cell carcinoma (LUSC). Contrasted with lung adenocarcinoma (LUAD), in which driver mutations in the epidermal growth factor receptor (EGFR) and other genes are detectable with high sensitivity, LUSC is challenging to identify, resulting in limited intervention options (2012; <a href="#B3" class="usa-link" aria-describedby="B3">3</a>). The identification of immune checkpoints like PD-1/PD-L1 and CTLA-4 has spurred the extensive application of immune checkpoint inhibitors (ICIs), pioneering new therapeutic pathways in oncology and enabling LUSC patients to reap the benefits of immunotherapy (<a href="#B4" class="usa-link" aria-describedby="B4">4</a>–<a href="#B6" class="usa-link" aria-describedby="B6">6</a>). The latest National Comprehensive Cancer Network (NCCN) guidelines advocate for anti-PD-1/L1 monotherapy as the standard second-line treatment for NSCLC, and PD-1 inhibitor monotherapy or its combination with chemotherapy as the standard first-line treatment for advanced NSCLC. For LUSC patients exhibiting PD-L1 positivity ≥50%, the recommended first-line treatment is immune monotherapy or a combination of chemotherapy and immunotherapy; for those with 1–49% PD-L1 positivity, the recommended first-line regimen is chemotherapy in conjunction with immunotherapy (<a href="#B7" class="usa-link" aria-describedby="B7">7</a>).</p>
<p>Immune checkpoint inhibitors, such as PD1/PD - L1, especially PD - L1 inhibitors, can concurrently bind to PD - L1 present on the surfaces of both tumor cells and antigen - presenting cells (APCs). This interaction restores T cell - mediated anti - tumor immunity (<a href="#B8" class="usa-link" aria-describedby="B8">8</a>). These inhibitors possess the capacity to impede the binding between PD - L1 on tumor cells and B7 - 1 on T cells (<a href="#B9" class="usa-link" aria-describedby="B9">9</a>, <a href="#B10" class="usa-link" aria-describedby="B10">10</a>), thereby comprehensively activating T cells. Moreover, the inhibitors can also alleviate the self - inhibition of dendritic cells (<a href="#B11" class="usa-link" aria-describedby="B11">11</a>), reinforcing anti - tumor immunity from multiple perspectives.</p>
<p>Combining immunotherapy with chemotherapy can enhance the immune response through multiple mechanisms. It can induce immunogenic cell death (<a href="#B12" class="usa-link" aria-describedby="B12">12</a>), increase the exposure of tumor antigens, and promote antigen presentation and T cell activation (<a href="#B11" class="usa-link" aria-describedby="B11">11</a>). Chemotherapeutic agents can directly target and kill tumor cells, initiating apoptosis and subsequently releasing tumor antigens. Additionally, they can trigger the immunogenic cell death (ICD) pathway (<a href="#B13" class="usa-link" aria-describedby="B13">13</a>, <a href="#B14" class="usa-link" aria-describedby="B14">14</a>). For instance, chemotherapeutic drugs like anthracyclines, platinum - based drugs, and taxanes can cause tumor cells to release damage - associated proteins during the process of cellular damage. These substances, known as damage - associated molecular patterns (DAMPs), include surface - exposed calreticulin (ecto - CRT), high - mobility group box 1 (HMGB1), heat shock proteins (HSPs), and extracellularly - released adenosine triphosphate (ATP). These DAMPs facilitate T cell infiltration and transform immunologically “cold” tumors into “hot” tumors. Ultimately, this leads to an augmentation of the tumor immune - inflammatory response and the induction of specific anti - tumor immune reactions.</p>
<p>In China, the standard treatment typically adheres to the most recent guidelines issued by CSCO(Chinese Society of Clinical Oncology) for the year of treatment. Regarding first-line treatment of LUSC lacking driver mutations, the Phase III IMpower110 study (<a href="#B15" class="usa-link" aria-describedby="B15">15</a>) demonstrated that atezolizumab markedly enhanced progression-free survival (PFS) and overall survival (OS) in patients with high PD-L1 expression in wild-type stage IV LUSC as compared to chemotherapy. The subsequent KEYNOTE-024 (<a href="#B16" class="usa-link" aria-describedby="B16">16</a>) and KEYNOTE-042 (<a href="#B17" class="usa-link" aria-describedby="B17">17</a>) studies corroborated that compared to chemotherapy, pembrolizumab significantly prolonged PFS and OS, diminished the frequency of adverse reactions, and substantially reduced the mortality risk for patients with PD-L1 TPS ≥ 1.Furthermore,the KEYNOTE-407 study revealed that the combination of immunotherapy and chemotherapy offered benefits to patients across various PD-L1 expression subgroups, as evidenced by the synergistic effects of pembrolizumab and chemotherapy. The RATIONALE-307 study indicated that the combination of tislelizumab with carboplatin and paclitaxel (or nab-paclitaxel) significantly extended PFS compared to the chemotherapy-only group (<a href="#B18" class="usa-link" aria-describedby="B18">18</a>).</p>
<p>Although the combination of immunotherapy and chemotherapy, as a first-line standard treatment for advanced LUSC was established in the KEYNOTE-407 study, treatment options for Chinese patients were previously constrained. Based on the data from the RATIONALE-307 study (<a href="#B18" class="usa-link" aria-describedby="B18">18</a>), drawing from a vast sample across various centers in China, tislelizumab received marketing approval, offering a more economical alternative to clinicians and cancer patients in China. This study presents a case of a patient with LUSC who achieved complete remission and cystic formation following treatment with the combination of tislelizumab and chemotherapy. Analogous cases have been documented in the literature. For instance, when inoperable tumors patients underwent 4-6 cycles of standard immunotherapy combined with chemotherapy some exhibited sustained regression of masses and lymph nodes and achieved complete remission, while others underwent surgical treatment after significant mass reduction and showed complete remission confirmed by pathology. The patient detailed in this report displayed an uncommon cystic radiological presentation after a mere 3 cycles treatment in combination with immunotherapy and chemotherapy. Subsequent to transitioning to the tislelizumab monotherapy due to adverse reactions associated with chemotherapy, successive follow-ups post 2 cycles revealed a progressive reduction in cyst size until it fully collapsed, culminating in complete remission. This distinctive radiological presentation visually underscores the synergistic advantage of combining immunotherapy with chemotherapy, which shows 1 + 1&gt;2. It is noteworthy that the subsequent use of tislelizumab monotherapy was not less effective, potentially furnishing significant evidence for the use of tislelizumab as a monotherapy. Discussing of the issues encountered during the course of the combined immunotherapy-chemotherapy, including adverse reactions, benefits post-discontinuation, and immune efficacy assessment, is merited to augment clinical experience for LUSC patients treated with tislelizumab.</p></section><section id="s2"><h2 class="pmc_sec_title">2. Case presentation</h2>
<p>A 73-year-old man presenting with paroxysmal cough and sputum accompanied by chest pain, weight loss, and exertional asthma was admitted to a local hospital on February 13, 2023. A chest computed tomography (CT) scan revealed a mass in the right upper lobe of the lung, raising the suspicion of a malignant tumor (MT). Subsequent positron electron tomography (PET)-CT indicated an irregular lobulated soft tissue mass in the apical segment of the right lung upper lobe, measuring approximately 4.1×3.5 cm and showing increased fluorodeoxyglucose (FDG) uptake (SUV value) and spiculated margins, suggestive of lung cancer (likely squamous cell carcinoma). There were tiny nodular shadows about 0.3 cm in diameter surrounding the mass, and the possibility of metastasis was not ruled out. Several enlarged lymph nodes were visible in regions 10R, 4R, and 2R, the largest measuring approximately 1.7 cm in diameter. that showed varying degrees of increased FDG uptake, suggesting possible metastasis in some lymph nodes. On March 3, 2023, a CT-guided biopsy of the right upper lobe lung mass was performed at our hospital. According to the pathology report (<a href="#f1" class="usa-link">
<strong>Figure 1</strong>
</a>), combined with the patient’s medical history and immunohistochemical markers, squamous cell carcinoma was considered (Note: CK7-, CK20-, CK5/6-, NapsinA-, CD56-, P40+, Syn-, CgA-, CD56-, TTF-1-, Ki-67 75%). As shown in the microscopic cellular morphology and tissue architecture of <a href="#f1" class="usa-link">
<strong>Figure 1</strong>
</a>, the entire field demonstrates complete loss of normal pulmonary tissue structure. Sheets of squamous cells with marked nuclear atypia are observed, accompanied by prominent keratinization features. PD-1/PD-L1 testing was not conducted. Based on the symptoms, signs, and test results, the patient was diagnosed with stage cT2bN2M0 right lung squamous cell carcinoma.</p>
<figure class="fig xbox font-sm" id="f1"><h3 class="obj_head">Figure 1.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11973309_fimmu-16-1543114-g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c48/11973309/8ddecee16715/fimmu-16-1543114-g001.jpg" loading="lazy" height="794" width="794" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/f1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(10×ocular/20×objective lens, total magnification×200, scale bar = 100μm): Small arrow: Squamous cells with marked atypia demonstrating enlarged hyperchromatic nuclei, irregular nuclear contours, and increased nuclear-to-cytoplasmic ratio; Square: Intracellular keratinization (dyskeratosis); Large arrow: Tumor cell nests surrounded by stromal tissue; Circled area: Perivascular hyperplasia; Overall architecture: No normal lung tissue architecture is evident throughout the imageStaining.</p></figcaption></figure><p>Due to old age, large lesions, and underlying diseases such as femoral head necrosis, surgery and radiotherapy are not considered for the patient. Following the guidelines of the Chinese Society of Clinical Oncology (CSCO),on March 14, 2023,immunotherapy combined with chemotherapy was started:paclitaxel liposome 240 mg on d1, carboplatin 500 mg on d1, and tislelizumab 200 mg on d2, every 3 weeks (q3w). Grade III thrombocytopenia occurred post-treatment, with a nadir of 30 × 10<sup>9</sup>/L. On April 18, 2023,the immunotherapy regimen was adjusted for the first cycle:tislelizumab 200 mg on d 0 + paclitaxel liposome 120 mg on d 1, 90 mg on d 8 + carboplatin 150 mg on d 2, 100 mg on d 3-5, every 3 weeks (q3w). However, on May 16, 2023, bacteremia and herpes zoster infection were observed, so antitumor treatment was halted. Vancomycin was given for anti - infection and anti - viral treatment. After active treatment, the first reexamination on May 29, 2023, with a repeat enhanced chest CT showed an irregular thin-walled cystic lesion in the right upper lobe with fine line compartments, measuring approximately 32×25×27 mm, with enlarged and moderately enhanced lymph nodes in the 10R, 4R, and 2R regions. Compared to the March 3, 2023 CT, the solid component of the right upper lobe mass had essentially disappeared, and the mediastinal lymph nodes were similar in size. Response assessment indicated partial remission, and the second cycle of immunotherapy combined with chemotherapy was administered on June 27, 2023.</p>
<p>After June 27, 2023, due to chemotherapy - induced bone marrow suppression and pre - existing heart and kidney dysfunction, the patient and family refused further chemotherapy. Anemia was corrected by infusion of leukocyte-reduced red blood cell suspension. Based on patient preferences, age, physical condition, imaging findings, and guidelines, two cycles of “tislelizumab 200 mg on day 0” monotherapy were administered on September 26 and November 27, 2023. Enhanced chest CT was again performed on November 27, 2023, showing an irregular cystic lesion approximately 31×20×22 mm beneath the pleura in the right upper lobe, with septation and moderately enlarged mediastinal lymph nodes. Compared to the previous scan, the cystic lesion in the right upper lobe had decreased slightly in size, with similar mediastinal lymph node enhancement. The patient and his family subsequently refused antitumor therapy due to personal reasons, and he was re-admitted for follow-up on April 8, 2024, after stopping immunotherapy for five months. This enhanced chest CT showed high-density cord-like shadows in place of the previously observed cystic lesions. Due to the lack of solid components of mediastinal window, it was impossible to evaluate the degree of enhancement of the dense cord-like shadows accurately, and the sizes of the mediastinal lymph nodes were similar to those seen previously.</p>
<p>To evaluate the curative effect more accurately, cranial MRI was performed, showing no metastases. Due to the patient’s and family members’ refusal to undergo PET-CT for the re-examination of metastatic lymph nodes and percutaneous pathological biopsy, we are only able to make a comprehensive assessment based on enhanced computed tomography (CT), tumor markers, and clinical symptoms. <a href="#f2" class="usa-link">
<strong>Figure 2</strong>
</a> clearly illustrates the patient’s imaging examination results spanning from 2023-03-28 to 2024-04-08, as well as the treatment regimens at different time intervals. The most recent CT reveals that the cystic cavity of the target lesion has completely collapsed, and the longest and shortest diameters of the mediastinal lymph nodes measure 9 mm. Concurrently, the levels of the serum tumor markers CSSA, CEA, NSE, and CYFR21-1 had decreased significantly compared to those observed on November 27, 2023,and the specific values are shown in <a href="#f3" class="usa-link">
<strong>Figure 3</strong>
</a>. According to the iRecist criteria, the efficacy was evaluated as complete remission.</p>
<figure class="fig xbox font-sm" id="f2"><h3 class="obj_head">Figure 2.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11973309_fimmu-16-1543114-g002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c48/11973309/9ad414861330/fimmu-16-1543114-g002.jpg" loading="lazy" height="517" width="784" alt="Figure 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/f2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>
<strong>(A)</strong> Irregular soft tissue shadows are seen in the anterior segment of the upper lobe of the right lung, with lobulated and spiculated margins; <strong>(B)</strong> Following treatment for right upper lobe lung cancer, there was an irregular thin-walled cystic lesion measuring approximately 32×25×27 mm, with irregular linear septations and sparse lamellar dense shadows along the inner edge of the cyst; <strong>(C)</strong> The cyst was reduced in size compared to before, measuring approximately 31×20×22 mm, with almost complete collapse compared to before, presenting as cord-like dense shadows. <strong>(E)</strong> The FDG metabolism in the hilum of the right lung and mediastinal lymph nodes was increased to varying degrees, with the largest node having a diameter of approximately 17 mm. In the mediastinum, nodes in regions 10R <strong>(b)</strong>, 4R, and 2R <strong>(a)</strong> were enlarged with moderate enhancement, with the largest nodes in 10R and 2R measuring approximately 16×10 mm. Regions 10R <strong>(d)</strong>, 4R, and 2R <strong>(c)</strong> also showed several enlarged nodes with moderate enhancement, similar in size to previous findings. Regions 10R <strong>(f)</strong>, 4R, and 2R <strong>(e)</strong> showed several enlarged nodes with moderate enhancement, similar in size to previous findings.</p></figcaption></figure><figure class="fig xbox font-sm" id="f3"><h3 class="obj_head">Figure 3.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11973309_fimmu-16-1543114-g003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c48/11973309/81f3e0d167a3/fimmu-16-1543114-g003.jpg" loading="lazy" height="507" width="763" alt="Figure 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/f3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>CSSA, Carcinoembryonic Antigen-related Sialic Acid-binding Adhesion Molecule; CEA, Carcinoembryonic Antigen; NSE, Neuron-Specific Enolase; CYFR21-1, Cytokeratin 19 Fragment.</p></figcaption></figure></section><section id="s3"><h2 class="pmc_sec_title">3. Discussion</h2>
<p>To date, there have been very few cases of complete remission achieved through drug treatment. A review of the literature identified a case report describing a patient with stage IVB LUSC who received a combination treatment of cisplatin/carboplatin, nab-paclitaxel, and tislelizumab. After 4 cycles, the patient showed a good response and achieved partial remission. Notably, the CT results indicated the disappearance of the main primary lesion in the left upper lung, resulting in the formation of a thick-walled cavity, while the lesion in the right lung was significantly reduced in size (CR1, <a href="#T1" class="usa-link">
<strong>Table 1</strong>
</a>). Additionally, there are related case reports where tislelizumab combined with chemotherapy was used for neoadjuvant therapy, resulting in successful reduction of the lesion, followed by surgery and subsequent complete pathological remission (CR2 and CR3, <a href="#T1" class="usa-link">
<strong>Table 1</strong>
</a>). Therefore, achieving complete remission through drug treatment alone in the present case is quite surprising and holds a certain significance and reference value in the real world.</p>
<section class="tw xbox font-sm" id="T1"><h3 class="obj_head">Table 1.</h3>
<div class="caption p"><p>Case reports on the use of tislelizumab combined with chemotherapy for LUSC.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th valign="middle" align="left" rowspan="1" colspan="1">Case Id</th>
<th valign="middle" align="center" rowspan="1" colspan="1">Basic Information</th>
<th valign="middle" align="center" rowspan="1" colspan="1">Diagnosis</th>
<th valign="middle" align="center" rowspan="1" colspan="1">Driver Gene</th>
<th valign="middle" align="center" rowspan="1" colspan="1">PD-1 and PD-L1 Expression</th>
<th valign="middle" align="center" rowspan="1" colspan="1">Treatment Objective</th>
<th valign="middle" align="center" rowspan="1" colspan="1">Drugs</th>
<th valign="middle" align="center" rowspan="1" colspan="1">Surgery</th>
<th valign="middle" align="center" rowspan="1" colspan="1">Efficacy Evaluation</th>
<th valign="middle" align="center" rowspan="1" colspan="1">Treatment Plan After First Evaluation</th>
<th valign="middle" align="center" rowspan="1" colspan="1">Adverse Reactions</th>
<th valign="middle" align="center" rowspan="1" colspan="1">References</th>
</tr></thead>
<tbody>
<tr>
<td valign="middle" align="left" rowspan="1" colspan="1">CR1</td>
<td valign="middle" align="center" rowspan="1" colspan="1">69-year-old male</td>
<td valign="middle" align="center" rowspan="1" colspan="1">Left lung IVB (cT4N2M1c) and right lung IVB (cT2N2M1c) LUSC</td>
<td valign="middle" align="center" rowspan="1" colspan="1">Not provided</td>
<td valign="middle" align="center" rowspan="1" colspan="1">Negative</td>
<td valign="middle" align="center" rowspan="1" colspan="1">First-line treatment</td>
<td valign="middle" align="center" rowspan="1" colspan="1">TP + Tislelizumab for 3 cycles, TC + Tislelizumab for 1 cycle</td>
<td valign="middle" align="center" rowspan="1" colspan="1">None</td>
<td valign="middle" align="center" rowspan="1" colspan="1">Partial remission</td>
<td valign="middle" align="center" rowspan="1" colspan="1">Tislelizumab</td>
<td valign="middle" align="center" rowspan="1" colspan="1">Hypothyroidism</td>
<td valign="middle" align="center" rowspan="1" colspan="1">(<a href="#B27" class="usa-link" aria-describedby="B27">27</a>)</td>
</tr>
<tr>
<td valign="middle" align="left" rowspan="1" colspan="1">CR2</td>
<td valign="middle" align="center" rowspan="1" colspan="1">45-year-old male</td>
<td valign="middle" align="center" rowspan="1" colspan="1">Inoperable stage IIIC (CT3N3MO) LUSC</td>
<td valign="middle" align="center" rowspan="1" colspan="1">Not provided</td>
<td valign="middle" align="center" rowspan="1" colspan="1">Not provided</td>
<td valign="middle" align="center" rowspan="1" colspan="1">Neoadjuvant treatment</td>
<td valign="middle" align="center" rowspan="1" colspan="1">TL + Tislelizumab for 2 cycles</td>
<td valign="middle" align="center" rowspan="1" colspan="1">Thoracoscopic left lower lung tumor resection and radical mediastinal lymph node dissection</td>
<td valign="middle" align="center" rowspan="1" colspan="1">Postoperative pathological complete remission</td>
<td valign="middle" align="center" rowspan="1" colspan="1">TL + Tislelizumab for 2 cycles, Tislelizumab for 12 months</td>
<td valign="middle" align="center" rowspan="1" colspan="1">Mild thyroid dysfunction</td>
<td valign="middle" align="center" rowspan="1" colspan="1">(<a href="#B28" class="usa-link" aria-describedby="B28">28</a>)</td>
</tr>
<tr>
<td valign="middle" align="left" rowspan="1" colspan="1">CR3</td>
<td valign="middle" align="center" rowspan="1" colspan="1">64-year-old male</td>
<td valign="middle" align="center" rowspan="1" colspan="1">Stage IIIB (cT3N2M0) right lung LUSC</td>
<td valign="middle" align="center" rowspan="1" colspan="1">No mutations</td>
<td valign="middle" align="center" rowspan="1" colspan="1">Negative</td>
<td valign="middle" align="center" rowspan="1" colspan="1">Neoadjuvant treatment</td>
<td valign="middle" align="center" rowspan="1" colspan="1">TC + Tislelizumab for 2 cycles</td>
<td valign="middle" align="center" rowspan="1" colspan="1">Thoracoscopic lung cancer resection</td>
<td valign="middle" align="center" rowspan="1" colspan="1">Postoperative pathological complete remission</td>
<td valign="middle" align="center" rowspan="1" colspan="1">Tislelizumab</td>
<td valign="middle" align="center" rowspan="1" colspan="1">Grade 2 bone marrow suppression</td>
<td valign="middle" align="center" rowspan="1" colspan="1">(<a href="#B29" class="usa-link" aria-describedby="B29">29</a>)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="fn3"><p>CR1-3: Case Report 1-3 TP: Paclitaxel + Cisplatin TC: Paclitaxel + Carboplatin TL: Nab-paclitaxel + LobaplatinPR: Partial response pCR: Pathological complete response.</p></div></div></section><p>In this case, the patient underwent re-examination CT after receiving two cycles of a standard regimen of immunotherapy combined with chemotherapy, and it was found that a cyst had formed at the original tumor site. This imaging presentation differs from what is commonly seen after lung cancer treatment. In this case, the solid component of the soft tissue mass in the right upper lobe disappeared rapidly after treatment, leaving irregular cysts. Since the cystic cavity shadow basically disappeared after regression, the presence of pre-existing cystic cavity changes in the lung, such as pulmonary bullae, pulmonary cysts and bronchiectasis, is not considered. In the absence of pathology, we believe that the formation of cystic cavities is caused by the following factors:(1) The tumor involved the small bronchi, causing local bronchial stenosis or obstruction, forming an “air valve effect,” resulting in air trapping (<a href="#B19" class="usa-link" aria-describedby="B19">19</a>); (2) The tumor had invaded the alveoli and the surrounding interstitial structure (<a href="#B20" class="usa-link" aria-describedby="B20">20</a>), causing alveolar fusion (<a href="#B21" class="usa-link" aria-describedby="B21">21</a>) and the formation of large cysts. When treatment was effective, after the tumor tissue disappeared, the remaining destroyed lung tissue formed irregular cysts, which then slowly collapsed. These cysts shrank gradually during the follow-up period, and re-examination after about one year showed that the cysts had collapsed, leading to the presentation of cord-like dense shadows. The mechanism of cystic cavities resulting from alveolar injury and pulmonary small airway obstruction may be similar to that of cystic lung cancer.</p>
<p>The formation of cystic cavities also has an impact on the direction of subsequent clinical decision-making. The chest enhanced CT on May 29 showed changes in the nature of the lesion, suggesting the disappearance of the tumor cells and the formation of cysts. However, previous PET-CT reports had suggested possible metastasis to surrounding lymph nodes, and the enhanced CT on May 29 still showed several enlarged, moderately enhanced lymph nodes in the mediastinum (<a href="#f2" class="usa-link">
<strong>Figure 2</strong>
</a>). At this time, the focus of the patient’s treatment lies in rapidly shrinking the tumor and controlling the disease progression. Therefore, continuing the immunotherapy combination treatment becomes the primary strategy after the first assessment.</p>
<p>Despite the promising efficacy of the combined immunotherapy and chemotherapy, the patient experienced grade III thrombocytopenia (with a nadir of 30×10<sup>9</sup>/L) and grade IV hemoglobin reduction (with a nadir of 49 g/L) on multiple occasions during the treatment. These were both considered to be chemotherapy - related bone marrow suppression. Moreover, severe bacteremia occurred, which significantly decreased the patient’s quality of life and led to a marked decline in the Karnofsky Performance Status (KPS) score. Meanwhile, the patient’s cardiac and renal functions remained suboptimal, with elevated levels of transaminase, creatinine, and B - type natriuretic peptide (BNP) to varying degrees. Based on these circumstances, the treatment team had thorough communication with the patient and their family to develop an individualized treatment plan suitable for this patient. On one hand, since the PD - L1 test had not been conducted, the PD - L1 expression was unclear, and it remained uncertain whether tislelizumab monotherapy could effectively maintain the current positive treatment trend. On the other hand, the “chemotherapy - free mode”, a subtractive approach, might ensure the continuation of the patient’s treatment plan and improve their quality of life simultaneously. Through patient - centered individualized diagnosis and treatment, the focus of treatment was ultimately defined as controlling the disease with low toxicity to ensure the quality of life. This approach achieved results that satisfied both the medical team and the patient.</p>
<p>ICIs primarily counteract immune suppression through specific inhibition of immune checkpoints, thereby enhancing existing antitumor immune responses at different stages of the tumor immune cycle. However, whether these responses persist after stopping immunotherapy is currently uncertain. The CheckMate 069 study showed that in some patients, treatment response can continue for a period even after discontinuation due to toxic reactions. It was found that 66% of patients continued to benefit after stopping immunotherapy, with complete response rates of 20%, partial response rates of 46%, and stable disease in 17%. The 2-year survival and PFS rates for cancer patients who discontinued immunotherapy were found to be 71% and 52%, respectively (<a href="#B22" class="usa-link" aria-describedby="B22">22</a>, <a href="#B23" class="usa-link" aria-describedby="B23">23</a>). In this case, the patient discontinued treatment due to personal reasons after the last dose, and the discontinuation lasted for 4 months. Although the skin rash remained during this period, the first follow-up imaging showed complete disappearance of the target lesions, with the largest short-axis diameter of enlarged lymph nodes measuring 9 mm, while non-target nodules remained unchanged at 4 mm, demonstrating a favorable immune smearing effect. Follow-up after discontinuation of immunotherapy is particularly important for this patient, and the absence of PET-CT and percutaneous pathological biopsy poses certain risks for tumor recurrence and metastasis. We will conduct regular enhanced CT examinations to closely monitor the size and enhancement pattern of the lymph node region. By fully combining the patient’s clinical symptoms with laboratory test results, we aim to ensure the detection of the disease condition and timely updating of the treatment plan.</p>
<p>In a clinical trial comparing tislelizumab plus paclitaxel and cisplatin versus chemotherapy alone in phase IIIb to IV NSCLC patients, the levels of serum biomarkers, the overall response rate, and the disease control rate were all significantly better in the tislelizumab group, although the incidence of adverse reactions did not differ significantly (<a href="#B18" class="usa-link" aria-describedby="B18">18</a>). Among ICI-induced immune-related adverse events (<a href="#B24" class="usa-link" aria-describedby="B24">24</a>), 30-50% of patients developed toxic reactions of the skin, including rash, pruritus, psoriatic lesions, and lichenoid dermatitis. Case reports have suggested that while tislelizumab has good safety, it can also cause skin rash and potentially induce bullous pemphigoid (BP), a severe autoimmune disorder (<a href="#B25" class="usa-link" aria-describedby="B25">25</a>, <a href="#B26" class="usa-link" aria-describedby="B26">26</a>).In this patient case, obvious rashes persisted during the immunotherapy - chemotherapy combination treatment and the subsequent monotherapy. Considering the patient’s history of femoral head necrosis, glucocorticoid treatment was not administered. During this period, timely consultations with dermatologists were carried out, and urea ointment was prescribed for treatment.</p>
<p>In addition to the rash, the patient manifested significant thrombocytopenia after the first treatment. Regarding this phenomenon, the local treatment team conducted an assessment of the bleeding risk. The patient displayed no obvious cutaneous ecchymoses or petechiae, had no epistaxis or oropharyngeal hemorrhage, and was given subcutaneous injection of rhTPO. In the efficacy evaluation of immunotherapy, about 80% of patients achieve their first remission around the first evaluation (6 weeks) or the second evaluation (12 weeks). After receiving 2 cycles of treatment, the evaluation of immunotherapeutic efficacy was of particular importance. However, at this time, the patient developed a high fever. Catheter blood culture revealed an infection of Acinetobacter baumannii, and peripheral blood culture demonstrated an infection of Pantoea agglomerans. After the treatment team administered piperacillin - tazobactam for catheter sealing, the C - reactive protein (CRP) level exhibited a decrease. Later, the patient had a high fever again. Re - examination of catheter and peripheral blood cultures indicated infections of Staphylococcus haemolyticus and Staphylococcus epidermidis. Taking into comprehensive consideration the concurrent bacteremia, the antibiotic was adjusted to vancomycin for anti - infection treatment. After treatment, the patient’s symptoms improved significantly. Re - examination of whole blood and catheter - derived blood cultures showed no bacterial growth for five consecutive days. Meanwhile, numerous erythemas and clustered blisters appeared on the left axilla and the flexor side of the upper arm of the patient. Herpes zoster was suspected, and symptomatic treatments such as antiviral therapy and nerve - nourishing treatment were given, and the patient’s renal function was closely monitored. Thanks to the good control of complications, the patient underwent the first evaluation as scheduled on May 29, 2023, and obtained gratifying results, providing sufficient confidence and basis for subsequent continuous treatment. The timely management of adverse reactions together with adjustments in treatment guided by clinical and guideline recommendations proved beneficial overall for this patient.</p>
<p>Currently, there are few reported cases of elderly patients with lung squamous cell carcinoma being successfully treated by PD-1 inhibitors combined with chemotherapy and subsequently forming cavities. This case is limited by the small amount of puncture samples, resulting in an insufficient number of subsequently prepared tissue white slides, and thus the PD-L1 status cannot be determined. However, after the sequential application of chemotherapy combined with immunotherapy and single-agent immunotherapy, a favorable outcome has still been achieved. Although this case still has certain limitations, it nevertheless provides a reference for the timing of clinical immunotherapy application and how to proceed with treatment in the specific situation of cyst formation.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>The authors would like to thank the research group at the Affiliated Hospital of Integrated Traditional Chinese and Western Medicine.</p></section><section id="funding-statement1" lang="en"><h2 class="pmc_sec_title">Funding Statement</h2>
<p>The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by the Key Projects of Medical Scientific Research Project Approval by the Jiangsu Provincial Health Commission in 2023(grant number K2023033).</p></section><section id="s4"><h2 class="pmc_sec_title">Data availability statement</h2>
<p>The original contributions presented in the study are included in the article/supplementary material. Further inquiries can be directed to the corresponding authors.</p></section><section id="s5"><h2 class="pmc_sec_title">Ethics statement</h2>
<p>The studies involving humans were approved by Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.</p></section><section id="s6"><h2 class="pmc_sec_title">Author contributions</h2>
<p>LX: Conceptualization, Data curation, Investigation, Methodology, Writing – original draft, Writing – review &amp; editing. XM: Data curation, Investigation, Methodology, Writing – original draft. YY: Data curation, Formal analysis, Methodology, Writing – review &amp; editing. ZD: Data curation, Methodology, Supervision, Visualization, Writing – review &amp; editing. YL: Funding acquisition, Resources, Software, Validation, Visualization, Writing – review &amp; editing.</p></section><section id="s8"><h2 class="pmc_sec_title">Conflict of interest</h2>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></section><section id="s9"><h2 class="pmc_sec_title">Generative AI statement</h2>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p></section><section id="s10"><h2 class="pmc_sec_title">Publisher’s note</h2>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="B1">
<span class="label">1.</span><cite>
Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. (2024) 74:229–63. doi:  10.3322/caac.21834
</cite> [<a href="https://doi.org/10.3322/caac.21834" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38572751/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=CA%20Cancer%20J%20Clin&amp;title=Global%20cancer%20statistics%202022:%20GLOBOCAN%20estimates%20of%20incidence%20and%20mortality%20worldwide%20for%2036%20cancers%20in%20185%20countries&amp;author=F%20Bray&amp;author=M%20Laversanne&amp;author=H%20Sung&amp;author=J%20Ferlay&amp;author=RL%20Siegel&amp;volume=74&amp;publication_year=2024&amp;pmid=38572751&amp;doi=10.3322/caac.21834&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B2">
<span class="label">2.</span><cite>
Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. (2018) 553:446–54. doi:  10.1038/nature25183
</cite> [<a href="https://doi.org/10.1038/nature25183" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29364287/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=The%20biology%20and%20management%20of%20non-small%20cell%20lung%20cancer&amp;author=RS%20Herbst&amp;author=D%20Morgensztern&amp;author=C%20Boshoff&amp;volume=553&amp;publication_year=2018&amp;pmid=29364287&amp;doi=10.1038/nature25183&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B3">
<span class="label">3.</span><cite>
Relli V, Trerotola M, Guerra E, Alberti S. Abandoning the notion of non-small cell lung cancer. Trends Mol Med. (2019) 25:585–94. doi:  10.1016/j.molmed.2019.04.012
</cite> [<a href="https://doi.org/10.1016/j.molmed.2019.04.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31155338/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trends%20Mol%20Med&amp;title=Abandoning%20the%20notion%20of%20non-small%20cell%20lung%20cancer&amp;author=V%20Relli&amp;author=M%20Trerotola&amp;author=E%20Guerra&amp;author=S%20Alberti&amp;volume=25&amp;publication_year=2019&amp;pmid=31155338&amp;doi=10.1016/j.molmed.2019.04.012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B4">
<span class="label">4.</span><cite>
Gettinger SN, Redman MW, Bazhenova L, Hirsch FR, Mack PC, Schwartz LH, et al. Nivolumab plus ipilimumab vs nivolumab for previously treated patients with stage IV squamous cell lung cancer: the lung-MAP S1400I phase 3 randomized clinical trial. JAMA Oncol. (2021) 7:1368–77. doi:  10.1001/jamaoncol.2021.2209
</cite> [<a href="https://doi.org/10.1001/jamaoncol.2021.2209" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8283667/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34264316/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Oncol&amp;title=Nivolumab%20plus%20ipilimumab%20vs%20nivolumab%20for%20previously%20treated%20patients%20with%20stage%20IV%20squamous%20cell%20lung%20cancer:%20the%20lung-MAP%20S1400I%20phase%203%20randomized%20clinical%20trial&amp;author=SN%20Gettinger&amp;author=MW%20Redman&amp;author=L%20Bazhenova&amp;author=FR%20Hirsch&amp;author=PC%20Mack&amp;volume=7&amp;publication_year=2021&amp;pmid=34264316&amp;doi=10.1001/jamaoncol.2021.2209&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B5">
<span class="label">5.</span><cite>
Paz-Ares L, Luft A, Vicente D, Tafreshi A, Gümüş M, Mazières J, et al. Pembrolizumab plus chemotherapy for squamous non-small-cell lung cancer. N Engl J Med. (2018) 379:2040–51. doi:  10.1056/NEJMoa1810865
</cite> [<a href="https://doi.org/10.1056/NEJMoa1810865" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30280635/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Pembrolizumab%20plus%20chemotherapy%20for%20squamous%20non-small-cell%20lung%20cancer&amp;author=L%20Paz-Ares&amp;author=A%20Luft&amp;author=D%20Vicente&amp;author=A%20Tafreshi&amp;author=M%20G%C3%BCm%C3%BC%C5%9F&amp;volume=379&amp;publication_year=2018&amp;pmid=30280635&amp;doi=10.1056/NEJMoa1810865&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B6">
<span class="label">6.</span><cite>
Network, Cancer Genome Atlas Research . Comprehensive genomic characterization of squamous cell lung cancers. Nature. (2012) 489:519–25. doi:  10.1038/nature11404
</cite> [<a href="https://doi.org/10.1038/nature11404" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3466113/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22960745/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Comprehensive%20genomic%20characterization%20of%20squamous%20cell%20lung%20cancers&amp;volume=489&amp;publication_year=2012&amp;pmid=22960745&amp;doi=10.1038/nature11404&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B7">
<span class="label">7.</span><cite>
National Comprehensive Cancer Network . Non-small cell lung cancer (Version 2.2023). Available online at: <a href="http://www.nccn.org" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.nccn.org</a> (Accessed February 17, 2023).</cite>
</li>
<li id="B8">
<span class="label">8.</span><cite>
Ohaegbulam KC, Assal A, Lazar-Molnar E, Yao Y, Zang X. Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway. Trends Mol Med. (2015) 21:24–33. doi:  10.1016/j.molmed.2014.10.009

</cite> [<a href="https://doi.org/10.1016/j.molmed.2014.10.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4282825/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25440090/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trends%20Mol%20Med&amp;title=Human%20cancer%20immunotherapy%20with%20antibodies%20to%20the%20PD-1%20and%20PD-L1%20pathway&amp;author=KC%20Ohaegbulam&amp;author=A%20Assal&amp;author=E%20Lazar-Molnar&amp;author=Y%20Yao&amp;author=X%20Zang&amp;volume=21&amp;publication_year=2015&amp;pages=24-33&amp;pmid=25440090&amp;doi=10.1016/j.molmed.2014.10.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B9">
<span class="label">9.</span><cite>
Sznol M, Chen L. Antagonist antibodies to PD-1 and B7-H1 (PD-L1) in the treatment of advanced human cancer. Clin Cancer Res. (2013) 19:1021–34. doi:  10.1158/1078-0432.Ccr-12-2063
</cite> [<a href="https://doi.org/10.1158/1078-0432.Ccr-12-2063" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3702373/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23460533/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&amp;title=Antagonist%20antibodies%20to%20PD-1%20and%20B7-H1%20(PD-L1)%20in%20the%20treatment%20of%20advanced%20human%20cancer&amp;author=M%20Sznol&amp;author=L%20Chen&amp;volume=19&amp;publication_year=2013&amp;pmid=23460533&amp;doi=10.1158/1078-0432.Ccr-12-2063&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B10">
<span class="label">10.</span><cite>
Butte MJ, Keir ME, Phamduy TB, Sharpe AH, Freeman GJ. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity. (2007) 27:111–22. doi:  10.1016/j.immuni.2007.05.016
</cite> [<a href="https://doi.org/10.1016/j.immuni.2007.05.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2707944/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17629517/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Immunity&amp;title=Programmed%20death-1%20ligand%201%20interacts%20specifically%20with%20the%20B7-1%20costimulatory%20molecule%20to%20inhibit%20T%20cell%20responses&amp;author=MJ%20Butte&amp;author=ME%20Keir&amp;author=TB%20Phamduy&amp;author=AH%20Sharpe&amp;author=GJ%20Freeman&amp;volume=27&amp;publication_year=2007&amp;pmid=17629517&amp;doi=10.1016/j.immuni.2007.05.016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B11">
<span class="label">11.</span><cite>
Heras-Murillo I, Adán-Barrientos I, Galán M, Wculek SK, Sancho D. Dendritic cells as orchestrators of anticancer immunity and immunotherapy. Nat Rev Clin Oncol. (2024) 21:257–77. doi:  10.1038/s41571-024-00859-1
</cite> [<a href="https://doi.org/10.1038/s41571-024-00859-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38326563/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Clin%20Oncol&amp;title=Dendritic%20cells%20as%20orchestrators%20of%20anticancer%20immunity%20and%20immunotherapy&amp;author=I%20Heras-Murillo&amp;author=I%20Ad%C3%A1n-Barrientos&amp;author=M%20Gal%C3%A1n&amp;author=SK%20Wculek&amp;author=D%20Sancho&amp;volume=21&amp;publication_year=2024&amp;pmid=38326563&amp;doi=10.1038/s41571-024-00859-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B12">
<span class="label">12.</span><cite>
Yi M, Zheng X, Niu M, Zhu S, Ge H, Wu K. Combination strategies with PD-1/PD-L1 blockade: current advances and future directions. Mol Cancer. (2022) 21:28. doi:  10.1186/s12943-021-01489-2

</cite> [<a href="https://doi.org/10.1186/s12943-021-01489-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8780712/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35062949/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Cancer&amp;title=Combination%20strategies%20with%20PD-1/PD-L1%20blockade:%20current%20advances%20and%20future%20directions&amp;author=M%20Yi&amp;author=X%20Zheng&amp;author=M%20Niu&amp;author=S%20Zhu&amp;author=H%20Ge&amp;volume=21&amp;publication_year=2022&amp;pages=28&amp;pmid=35062949&amp;doi=10.1186/s12943-021-01489-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B13">
<span class="label">13.</span><cite>
Xie D, Wang Q, Wu G. Research progress in inducing immunogenic cell death of tumor cells. Front Immunol. (2022) 13:1017400. doi:  10.3389/fimmu.2022.1017400

</cite> [<a href="https://doi.org/10.3389/fimmu.2022.1017400" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9712455/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36466838/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Immunol&amp;title=Research%20progress%20in%20inducing%20immunogenic%20cell%20death%20of%20tumor%20cells&amp;author=D%20Xie&amp;author=Q%20Wang&amp;author=G%20Wu&amp;volume=13&amp;publication_year=2022&amp;pages=1017400&amp;pmid=36466838&amp;doi=10.3389/fimmu.2022.1017400&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B14">
<span class="label">14.</span><cite>
Krysko DV, Garg AD, Kaczmarek A, Krysko O, Agostinis P, Vandenabeele P. Immunogenic cell death and DAMPs in cancer therapy. Nat Rev Cancer. (2012) 12:860–75. doi:  10.1038/nrc3380
</cite> [<a href="https://doi.org/10.1038/nrc3380" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23151605/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Cancer&amp;title=Immunogenic%20cell%20death%20and%20DAMPs%20in%20cancer%20therapy&amp;author=DV%20Krysko&amp;author=AD%20Garg&amp;author=A%20Kaczmarek&amp;author=O%20Krysko&amp;author=P%20Agostinis&amp;volume=12&amp;publication_year=2012&amp;pmid=23151605&amp;doi=10.1038/nrc3380&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B15">
<span class="label">15.</span><cite>
Jassem J, de Marinis F, Giaccone G, Vergnenegre A, Barrios CH, Morise M, et al. Updated overall survival analysis from IMpower110: atezolizumab versus platinum-based chemotherapy in treatment-naive programmed death-ligand 1-selected NSCLC. J Thorac Oncol. (2021) 16:1872–82. doi:  10.1016/j.jtho.2021.06.019
</cite> [<a href="https://doi.org/10.1016/j.jtho.2021.06.019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34265434/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Thorac%20Oncol&amp;title=Updated%20overall%20survival%20analysis%20from%20IMpower110:%20atezolizumab%20versus%20platinum-based%20chemotherapy%20in%20treatment-naive%20programmed%20death-ligand%201-selected%20NSCLC&amp;author=J%20Jassem&amp;author=F%20de%20Marinis&amp;author=G%20Giaccone&amp;author=A%20Vergnenegre&amp;author=CH%20Barrios&amp;volume=16&amp;publication_year=2021&amp;pmid=34265434&amp;doi=10.1016/j.jtho.2021.06.019&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B16">
<span class="label">16.</span><cite>
Reck M, Rodríguez-Abreu D, Robinson AG, Hui R, Csőszi T, Fülöp A, et al. Updated analysis of KEYNOTE-024: pembrolizumab versus platinum-based chemotherapy for advanced non-small-cell lung cancer with PD-L1 tumor proportion score of 50% or greater. J Clin Oncol. (2019) 37:537–46. doi:  10.1200/jco.18.00149
</cite> [<a href="https://doi.org/10.1200/jco.18.00149" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30620668/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=Updated%20analysis%20of%20KEYNOTE-024:%20pembrolizumab%20versus%20platinum-based%20chemotherapy%20for%20advanced%20non-small-cell%20lung%20cancer%20with%20PD-L1%20tumor%20proportion%20score%20of%2050%%20or%20greater&amp;author=M%20Reck&amp;author=D%20Rodr%C3%ADguez-Abreu&amp;author=AG%20Robinson&amp;author=R%20Hui&amp;author=T%20Cs%C5%91szi&amp;volume=37&amp;publication_year=2019&amp;pmid=30620668&amp;doi=10.1200/jco.18.00149&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B17">
<span class="label">17.</span><cite>
Mok TSK, Wu YL, Kudaba I, Kowalski DM, Cho BC, Turna HZ, et al. Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial. Lancet. (2019) 393:1819–30. doi:  10.1016/s0140-6736(18)32409-7
</cite> [<a href="https://doi.org/10.1016/s0140-6736(18)32409-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30955977/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Pembrolizumab%20versus%20chemotherapy%20for%20previously%20untreated,%20PD-L1-expressing,%20locally%20advanced%20or%20metastatic%20non-small-cell%20lung%20cancer%20(KEYNOTE-042):%20a%20randomised,%20open-label,%20controlled,%20phase%203%20trial&amp;author=TSK%20Mok&amp;author=YL%20Wu&amp;author=I%20Kudaba&amp;author=DM%20Kowalski&amp;author=BC%20Cho&amp;volume=393&amp;publication_year=2019&amp;pmid=30955977&amp;doi=10.1016/s0140-6736(18)32409-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B18">
<span class="label">18.</span><cite>
Wang J, Lu S, Yu X, Hu Y, Sun Y, Wang Z, et al. Tislelizumab plus chemotherapy vs chemotherapy alone as first-line treatment for advanced squamous non-small-cell lung cancer: A phase 3 randomized clinical trial. JAMA Oncol. (2021) 7:709–17. doi:  10.1001/jamaoncol.2021.0366
</cite> [<a href="https://doi.org/10.1001/jamaoncol.2021.0366" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8017481/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33792623/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Oncol&amp;title=Tislelizumab%20plus%20chemotherapy%20vs%20chemotherapy%20alone%20as%20first-line%20treatment%20for%20advanced%20squamous%20non-small-cell%20lung%20cancer:%20A%20phase%203%20randomized%20clinical%20trial&amp;author=J%20Wang&amp;author=S%20Lu&amp;author=X%20Yu&amp;author=Y%20Hu&amp;author=Y%20Sun&amp;volume=7&amp;publication_year=2021&amp;pmid=33792623&amp;doi=10.1001/jamaoncol.2021.0366&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B19">
<span class="label">19.</span><cite>
Lee KC, Kang EY, Yong HS, Kim C, Lee KY, Hwang SH, et al. A stepwise diagnostic approach to cystic lung diseases for radiologists. Korean J Radiol. (2019) 20:1368–80. doi:  10.3348/kjr.2019.0057
</cite> [<a href="https://doi.org/10.3348/kjr.2019.0057" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6715565/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31464115/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Korean%20J%20Radiol&amp;title=A%20stepwise%20diagnostic%20approach%20to%20cystic%20lung%20diseases%20for%20radiologists&amp;author=KC%20Lee&amp;author=EY%20Kang&amp;author=HS%20Yong&amp;author=C%20Kim&amp;author=KY%20Lee&amp;volume=20&amp;publication_year=2019&amp;pmid=31464115&amp;doi=10.3348/kjr.2019.0057&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B20">
<span class="label">20.</span><cite>
Travis WD, Eisele M, Nishimura KK, Aly RG, Bertoglio P, Chou TY, et al. The international association for the study of lung cancer (IASLC) staging project for lung cancer: recommendation to introduce spread through air spaces as a histologic descriptor in the ninth edition of the TNM classification of lung cancer. Analysis of 4061 pathologic stage I NSCLC. J Thorac Oncol. (2024) 19:1028–51. doi:  10.1016/j.jtho.2024.03.015
</cite> [<a href="https://doi.org/10.1016/j.jtho.2024.03.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38508515/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Thorac%20Oncol&amp;title=The%20international%20association%20for%20the%20study%20of%20lung%20cancer%20(IASLC)%20staging%20project%20for%20lung%20cancer:%20recommendation%20to%20introduce%20spread%20through%20air%20spaces%20as%20a%20histologic%20descriptor%20in%20the%20ninth%20edition%20of%20the%20TNM%20classification%20of%20lung%20cancer.%20Analysis%20of%204061%20pathologic%20stage%20I%20NSCLC&amp;author=WD%20Travis&amp;author=M%20Eisele&amp;author=KK%20Nishimura&amp;author=RG%20Aly&amp;author=P%20Bertoglio&amp;volume=19&amp;publication_year=2024&amp;pmid=38508515&amp;doi=10.1016/j.jtho.2024.03.015&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B21">
<span class="label">21.</span><cite>
Qu G, Shi Y. Progress on the study of tumor spread through air spaces in the clinicopathological characteristics of lung adenocarcinoma and its influence on the surgical treatment and prognosis of lung cancer. Chin J Lung (Cancer Zhongguo Fei Ai Za Zh). (2019) 22:363–8. doi:  10.3779/j.issn.1009-3419.2019.06.06
</cite> [<a href="https://doi.org/10.3779/j.issn.1009-3419.2019.06.06" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6580081/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31196370/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chin%20J%20Lung%20(Cancer%20Zhongguo%20Fei%20Ai%20Za%20Zh)&amp;title=Progress%20on%20the%20study%20of%20tumor%20spread%20through%20air%20spaces%20in%20the%20clinicopathological%20characteristics%20of%20lung%20adenocarcinoma%20and%20its%20influence%20on%20the%20surgical%20treatment%20and%20prognosis%20of%20lung%20cancer&amp;author=G%20Qu&amp;author=Y%20Shi&amp;volume=22&amp;publication_year=2019&amp;pmid=31196370&amp;doi=10.3779/j.issn.1009-3419.2019.06.06&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B22">
<span class="label">22.</span><cite>
Gauci ML, Lanoy E, Champiat S, Caramella C, Ammari S, Aspeslagh S, et al. Long-term survival in patients responding to anti-PD-1/PD-L1 therapy and disease outcome upon treatment discontinuation. Clin Cancer Res. (2019) 25:946–56. doi:  10.1158/1078-0432.Ccr-18-0793
</cite> [<a href="https://doi.org/10.1158/1078-0432.Ccr-18-0793" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30297458/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&amp;title=Long-term%20survival%20in%20patients%20responding%20to%20anti-PD-1/PD-L1%20therapy%20and%20disease%20outcome%20upon%20treatment%20discontinuation&amp;author=ML%20Gauci&amp;author=E%20Lanoy&amp;author=S%20Champiat&amp;author=C%20Caramella&amp;author=S%20Ammari&amp;volume=25&amp;publication_year=2019&amp;pmid=30297458&amp;doi=10.1158/1078-0432.Ccr-18-0793&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B23">
<span class="label">23.</span><cite>
Regan MM, Werner L, Rao S, Gupte-Singh K, Hodi FS, Kirkwood JM, et al. Treatment-free survival: A novel outcome measure of the effects of immune checkpoint inhibition-A pooled analysis of patients with advanced melanoma. J Clin Oncol. (2019) 37:3350–8. doi:  10.1200/jco.19.00345
</cite> [<a href="https://doi.org/10.1200/jco.19.00345" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6901280/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31498030/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=Treatment-free%20survival:%20A%20novel%20outcome%20measure%20of%20the%20effects%20of%20immune%20checkpoint%20inhibition-A%20pooled%20analysis%20of%20patients%20with%20advanced%20melanoma&amp;author=MM%20Regan&amp;author=L%20Werner&amp;author=S%20Rao&amp;author=K%20Gupte-Singh&amp;author=FS%20Hodi&amp;volume=37&amp;publication_year=2019&amp;pmid=31498030&amp;doi=10.1200/jco.19.00345&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B24">
<span class="label">24.</span><cite>
Esen BH, Özbek L, Oğuz S, Selçukbiricik F. Characterizing immune checkpoint inhibitor-related cutaneous adverse reactions: A comprehensive analysis of FDA adverse event reporting system (FAERS) database. Heliyon. (2024) 10:e33765. doi:  10.1016/j.heliyon.2024.e33765

</cite> [<a href="https://doi.org/10.1016/j.heliyon.2024.e33765" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11283008/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39071598/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Heliyon&amp;title=Characterizing%20immune%20checkpoint%20inhibitor-related%20cutaneous%20adverse%20reactions:%20A%20comprehensive%20analysis%20of%20FDA%20adverse%20event%20reporting%20system%20(FAERS)%20database&amp;author=BH%20Esen&amp;author=L%20%C3%96zbek&amp;author=S%20O%C4%9Fuz&amp;author=F%20Sel%C3%A7ukbiricik&amp;volume=10&amp;publication_year=2024&amp;pages=e33765&amp;pmid=39071598&amp;doi=10.1016/j.heliyon.2024.e33765&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B25">
<span class="label">25.</span><cite>
Lan JIN, Wang P, Ding Y, Liang J, Kang X. A case of bullous pemphigoid caused by tirelizumab. Chin J Hosp Pharm. (2023) 43:2231–3. doi:  10.13286/j.1001-5213.2023.19.18
</cite> [<a href="https://doi.org/10.13286/j.1001-5213.2023.19.18" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chin%20J%20Hosp%20Pharm&amp;title=A%20case%20of%20bullous%20pemphigoid%20caused%20by%20tirelizumab&amp;author=JIN%20Lan&amp;author=P%20Wang&amp;author=Y%20Ding&amp;author=J%20Liang&amp;author=X%20Kang&amp;volume=43&amp;publication_year=2023&amp;doi=10.13286/j.1001-5213.2023.19.18&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B26">
<span class="label">26.</span><cite>
Phillips GS, Wu J, Hellmann MD, Postow MA, Rizvi NA, Freites-Martinez A, et al. Treatment outcomes of immune-related cutaneous adverse events. J Clin Oncol. (2019) 37:2746–58. doi:  10.1200/jco.18.02141
</cite> [<a href="https://doi.org/10.1200/jco.18.02141" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7001790/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31216228/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=Treatment%20outcomes%20of%20immune-related%20cutaneous%20adverse%20events&amp;author=GS%20Phillips&amp;author=J%20Wu&amp;author=MD%20Hellmann&amp;author=MA%20Postow&amp;author=NA%20Rizvi&amp;volume=37&amp;publication_year=2019&amp;pmid=31216228&amp;doi=10.1200/jco.18.02141&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B27">
<span class="label">27.</span><cite>
Wu Q, Cao Y, Li Y, Jiang N, Dong H, Dong Y, et al. Successful treatment of two patients with unresectable lung squamous cell carcinoma with tislelizumab regardless of programmed death-ligand 1 expression: a report of two cases. Anticancer Drugs. (2022) 33:e828–33. doi:  10.1097/cad.0000000000001238
</cite> [<a href="https://doi.org/10.1097/cad.0000000000001238" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8670356/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34459453/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Anticancer%20Drugs&amp;title=Successful%20treatment%20of%20two%20patients%20with%20unresectable%20lung%20squamous%20cell%20carcinoma%20with%20tislelizumab%20regardless%20of%20programmed%20death-ligand%201%20expression:%20a%20report%20of%20two%20cases&amp;author=Q%20Wu&amp;author=Y%20Cao&amp;author=Y%20Li&amp;author=N%20Jiang&amp;author=H%20Dong&amp;volume=33&amp;publication_year=2022&amp;pmid=34459453&amp;doi=10.1097/cad.0000000000001238&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B28">
<span class="label">28.</span><cite>
Fu Y, Duan W, Xu R, Chen J. Conversion therapy with immunotherapy plus chemotherapy achieves a pathological complete response in stage IIIC NSCLC. Front Immunol. (2023) 14:1268153. doi:  10.3389/fimmu.2023.1268153

</cite> [<a href="https://doi.org/10.3389/fimmu.2023.1268153" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10655236/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38022567/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Immunol&amp;title=Conversion%20therapy%20with%20immunotherapy%20plus%20chemotherapy%20achieves%20a%20pathological%20complete%20response%20in%20stage%20IIIC%20NSCLC&amp;author=Y%20Fu&amp;author=W%20Duan&amp;author=R%20Xu&amp;author=J%20Chen&amp;volume=14&amp;publication_year=2023&amp;pages=1268153&amp;pmid=38022567&amp;doi=10.3389/fimmu.2023.1268153&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B29">
<span class="label">29.</span><cite>
Cui G, Qu D, Bai Y, Sun X, Li Y, Yang Y. Postoperative pathological complete response in a patient with PD−L1−negative stage IIIB lung squamous cell carcinoma following neoadjuvant tislelizumab treatment combined with chemotherapy: A case report and literature review. Oncol Lett. (2023) 26:388. doi:  10.3892/ol.2023.13974

</cite> [<a href="https://doi.org/10.3892/ol.2023.13974" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10407863/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37559583/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncol%20Lett&amp;title=Postoperative%20pathological%20complete%20response%20in%20a%20patient%20with%20PD%E2%88%92L1%E2%88%92negative%20stage%20IIIB%20lung%20squamous%20cell%20carcinoma%20following%20neoadjuvant%20tislelizumab%20treatment%20combined%20with%20chemotherapy:%20A%20case%20report%20and%20literature%20review&amp;author=G%20Cui&amp;author=D%20Qu&amp;author=Y%20Bai&amp;author=X%20Sun&amp;author=Y%20Li&amp;volume=26&amp;publication_year=2023&amp;pages=388&amp;pmid=37559583&amp;doi=10.3892/ol.2023.13974&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The original contributions presented in the study are included in the article/supplementary material. Further inquiries can be directed to the corresponding authors.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Frontiers in Immunology are provided here courtesy of <strong>Frontiers Media SA</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.3389/fimmu.2025.1543114"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/fimmu-16-1543114.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (3.2 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/11973309/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/11973309/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC11973309%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC11973309/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC11973309/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC11973309/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40196110/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC11973309/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40196110/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC11973309/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/11973309/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="6J4wfNP8ppuDfIGVAJsnYQzoXaT77aizBTM1eyTtKvjhi0MFq4Yf6MNEFUOBvLf2">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-370d5dd6.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-917ba005.js"></script>
    
    

    </body>
</html>
